Diagnostics

Quantified Diagnostic Technology to Aid Clinical Decisions

WAVi is FDA 510(k) cleared (K213900) and TM-Flow runs on three cleared modules; each gives you quantified data that aids clinical decisions and does not replace them. WAVi reads brain function. TM-Flow reads cardiovascular plus autonomic. Max Pulse adds chairside pulse-wave screening, and PreCheckHealth panels add the molecular layer.

Four tools, one patient

Two main platforms. Two adjacent tools.

WAVi · brain function, EEG and ERP
TM-Flow · cardiovascular plus autonomic
Max Pulse · chairside pulse-wave screening
Genetic Panels · molecular layer via PreCheckHealth
Proven, Not Promised · FDA 510(k) cleared diagnostics · Coverage decided by the payer · Baseline · Treat · Retest
The Platforms

Which diagnostics does TITN place?

Two flagship platforms carry the diagnostic load. WAVi (FDA 510(k) K213900) measures brain function through EEG and event-related potentials. TM-Flow (LD Technology) reads cardiovascular plus autonomic function in one visit, built on three separately FDA 510(k)-cleared modules. Coverage for both is decided by the payer on the documented indication. Max Pulse and the PreCheckHealth genetic panels extend the picture without adding billing complexity.

Main platform
WAVi Scan System headset
Brain · EEG / ERP
WAVi Scan System

Captures EEG and event-related potentials to aid in cognitive assessment, sports and injury baselining, and longitudinal brain monitoring. Retest frequency is decided by your payer on documented medical necessity. Wellness programs: before and after treatment, typically 4 to 6 weeks or 12 weeks.

Coverage Decided by your payer The scan is billed under the standard codes for the services performed, and your payer decides each line. The physician's cognitive assessment visit is billed separately, only when it is performed and documented. Ask us for the coverage checklist and worksheet.
FDA 510(k) K213900 Coverage by contractor and plan
Aid in diagnosisOpen page →
Main platform
TM-Flow System workstation, ANS / SUDO / ABI
Cardio · Autonomic · Vascular
TM-Flow System
(ANS, SUDO, ABI)

One workstation, three modules: autonomic function, sudomotor response, and ankle-brachial index in a single ten-minute visit. Built on three separately FDA 510(k)-cleared modules (K173696, K152216, K200141).

Coverage Decided by your payer Coding is pending a certified coder's written opinion. Coverage and coding are set by your Medicare contractor and each plan; California's contractor publishes no autonomic policy. Ask us for the coverage checklist and worksheet.
K173696 · K152216 · K200141 Coverage by contractor and plan
LD TechnologyOpen page →
Max Pulse cardiovascular testing device
Cardio · Pulse wave
Max Pulse

Chairside pulse-wave screening for cardiovascular wellness markers. One-to-three-minute test, immediate report. A screening tool, not a replacement for formal cardiac workup.

Coverage Cash pay No code is published for it. Ask us for the coverage checklist and worksheet.
FDA 510(k) K110374 Wellness screen
Cardiovascular Testing DeviceOpen page →
Clinical genetic panels via PreCheckHealth
Molecular · Patient referral
Genetic Panels
via PreCheckHealth · CLIA + CAP

Four clinical-grade panels: PharmacoCheck+, CancerCheck (116 genes), ImmunoCheck (291 genes), and Comprehensive Neurogenetic (203 genes). Provider-ordered through PreCheckHealth, not direct-to-consumer.

How it works Patient referral PreCheckHealth handles the panel billing. Clinic adds depth without billing lift.
CLIA + CAP accredited lab Pharma · Cancer · Immuno · Neuro
PreCheckHealthOpen panel guide →
How It Fits

Baseline. Treat. Retest.

Diagnostics are not a one-time snapshot. They anchor the TITN methodology: capture an measured baseline, treat against what the data shows, then retest to show what changed. Instead of asking a patient whether they feel better, you show them, and their payer, exactly what changed.

01

Baseline

FDA-cleared diagnostic captures quantified biomarkers: heart rate variability, sudomotor function, brain wave patterns, cognitive processing speed, evoked potentials. Documented before any intervention.

02

Treat

Evidence-based treatment protocol where applicable (ALTMS is FDA cleared for MDD), paired where appropriate with general-wellness modalities like photobiomodulation, hyperbaric, or hydrogen, tied to the baseline findings.

03

Retest

Identical protocol. Retest frequency is decided by your payer on documented medical necessity. Wellness programs: before and after treatment, typically 4 to 6 weeks (acute) or 12 weeks (chronic). Side-by-side reports show what changed.

Three ways to start.

Pick how you want to evaluate the diagnostics. No commitment past the first conversation.

Prefer email? support@transitionitnow.com  ·  (213) 444-6123  ·  Santa Monica, CA
Sources & verification Every FDA clearance and coverage statement on this page traces to a live source. View the sources

Every FDA clearance and coverage statement on this page traces to a live primary source: the FDA 510(k) database (openFDA), CMS coverage and fee-schedule pages, and device manufacturers. TITN publishes no reimbursement figure on this site; coverage is decided by the payer. All diagnostics aid clinical decisions and do not replace clinical judgment.